Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03414905 · ClinicalTrials.gov registry record
Management of Malignant Pleural Effusions Using an Indwelling Tunneled Pleural Catheter and Non-Vacuum Collection System
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 40
- Enrollment target
NCT03414905 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 40 participants.
The verdict
NCT03414905 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
In this study, the investigators will collect data on patients who are using the Aspira system as part of their clinical care for the management of recurrent pleural effusion. Data will be collected on patient demographics, placement of the pleural catheter, palliation of dyspnea, complication rates, and rates of spontaneous pleurodesis.
Interventions
- PROCEDURE Ultrasound
- DEVICE Aspira Catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-07-09 |
| Est. Completion | 2024-02-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03414905
The ClinicalTrials.gov registry entry for NCT03414905 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ultrasound is the first listed.
NCT03414905 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03414905 about?
NCT03414905 is a clinical study titled "Management of Malignant Pleural Effusions Using an Indwelling Tunneled Pleural Catheter and Non-Vacuum Collection System". In this study, the investigators will collect data on patients who are using the Aspira system as part of their clinical care for the management of recurrent pleural effusion. Data will be collected on patient demographics, placement of the pleural catheter, palliation of dyspnea, complication rates...
What is the current status of trial NCT03414905?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2018-07-09. Estimated completion is 2024-02-15.
What interventions are being tested in trial NCT03414905?
The interventions under investigation include: Ultrasound (PROCEDURE), Aspira Catheter (DEVICE).
Who is sponsoring clinical trial NCT03414905?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.